Publications by authors named "Sebastian Michael"

Claim this Profile
O
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study.
John E Harris, Kim Papp, Khaled Ezzedine, Michael Sebastian, Amit G Pandya

Br J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community Pharmacy Service for Patients With Inhaled Medications: A Multi-Perspective Observation and Assessment Under Routine Conditions.
Ann-Christin Kroenert, Lucas Freyberg, Claudia Sehmisch, Sebastian Michael, Thilo Bertsche

J Eval Clin Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
Linda Stein Gold, April W Armstrong, Robert Bissonnette, Nina Magnolo, Ronald B Vender, Michael Sebastian, Michael Cecchini

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injector.
Michael Sebastian, Jerry Bagel, Bengt Hoepken, Bertram Knapp, Ceyhun Bicer

Dermatol Ther (Heidelb)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Burnout among Nursing Students in Bangalore: A t-Distributed Stochastic Neighbor Embedding Analysis and Hierarchical Clustering in Cross-Sectional Data.
Michael Sebastian, Maddalena De Maria, Rosario Caruso, Gennaro Rocco, Cristina Di Pasquale

Nurs Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS).
Diamant Thaçi, Andreas Pinter, Michael Sebastian, Christian Termeer, Michael Sticherling

Br J Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' Use of a Standardized Medication List - A Mixed Methods Study.
Christiane Eickhoff, Uta Müller, Sophie Thomas, Christian Schmidt, Lisa Sophie Hartling, Sebastian Michael

Patient Prefer Adherence· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indication for systemic therapy in chronic prurigo: Annotated checklist for practice.
Matthias Augustin, Claudia Zeidler, Ralph von Kiedrowski, Martin Metz, Ulf Darsow, Michael Sebastian

J Dtsch Dermatol Ges· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Indikation zur Systemtherapie bei chronischer Prurigo: Kommentierte Checkliste für die Praxis].
Matthias Augustin, Claudia Zeidler, Ralph von Kiedrowski, Martin Metz, Ulf Darsow, Michael Sebastian

J Dtsch Dermatol Ges· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data.
Nowell Solish, Benjamin Ascher, Rui L Avelar, Vince Bertucci, Isaac Bodokh, Michael Sebastian

Aesthet Surg J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-efficacy, burnout and academic success in nursing students: A counterfactual mediation analysis.
Giampiera Bulfone, Paolo Iovino, Rocco Mazzotta, Michael Sebastian, Loreana Macale

J Adv Nurs· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial.
Mauro Picardo, Carla Cardinali, Michelangelo La Placa, Anita Lewartowska-Białek, Viviana Lora, Michael Sebastian

Br J Dermatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis.
Jerry Bagel, Daljit Tatla, Scarlett Hellot, Bertram Knapp, Charita Murphy, Michael Sebastian

J Drugs Dermatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität.
Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf-Henning Boehncke, Peter Härle, Hans-Michael Ockenfels, Michael Sebastian

J Dtsch Dermatol Ges· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 2: Treatment monitoring and specific clinical or comorbid situations.
Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf-Henning Boehncke, Peter Härle, Hans-Michael Ockenfels, Michael Sebastian

J Dtsch Dermatol Ges· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf-Henning Boehncke, Peter Härle, Hans-Michael Ockenfels, Michael Sebastian

J Dtsch Dermatol Ges· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 1: Treatment goals and treatment recommendations.
Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf-Henning Boehncke, Peter Härle, Hans-Michael Ockenfels, Michael Sebastian

J Dtsch Dermatol Ges· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhinoceros-related delayed traumatic diaphragmatic rupture.
Michael Sebastian, Alia Abdullah, Mohamed Abusharia, Fikri M Abu-Zidan

Ulus Travma Acil Cerrahi Derg· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Berthold-Josef Rzany, Benjamin Ascher, Rui L Avelar, Jesper Bergdahl, Vince Bertucci, Michael Sebastian

Aesthet Surg J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 2 - Besondere Patientengruppen und spezielle Behandlungssituationen.
Alexander Nast, Lasse Amelunxen, Matthias Augustin, Wolf-Henning Boehncke, Corinna Dressler, Hans-Michael Ockenfels, Michael Sebastian

J Dtsch Dermatol Ges· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 2 - Special patient populations and treatment situations.
Alexander Nast, Lasse Amelunxen, Matthias Augustin, Wolf-Henning Boehncke, Corinna Dressler, Hans-Michael Ockenfels, Michael Sebastian

J Dtsch Dermatol Ges· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment.
Alexander Nast, Lasse Amelunxen, Matthias Augustin, Wolf-Henning Boehncke, Corinna Dressler, Hans-Michael Ockenfels, Michael Sebastian

J Dtsch Dermatol Ges· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 1 - Systemische Therapie.
Alexander Nast, Lasse Amelunxen, Matthias Augustin, Wolf-Henning Boehncke, Corinna Dressler, Hans-Michael Ockenfels, Michael Sebastian

J Dtsch Dermatol Ges· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.
Michael Schwameis, Thomas Kündig, Gustave Huber, Luzi von Bidder, Lorenz Meinel, Michael Sebastian

Lancet Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blunt traumatic tension chylothorax: Case report and mini-review of the literature.
Kamal Idris, Michael Sebastian, Ashraf F Hefny, Navidul Haq Khan, Fikri M Abu-Zidan

World J Clin Cases· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis